Innovita Biological Technology Co. Ltd. A (688253) — Free Cash Flow Generation Index

Latest as of December 2025: 0.84x

Innovita Biological Technology Co. Ltd. A (688253) has a Free Cash Flow Generation Index of 0.84x as of December 2025. Free cash flow of CN¥162.00 Million represents 1% of operating cash flow (CN¥193.13 Million). Read total liabilities of Innovita Biological Technology Co. Ltd. for a breakdown of total debt and financial obligations.

FCF Generation Index

0.84x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥162.00 Million
CNY

Operating Cash Flow

CN¥193.13 Million
CNY

Capital Expenditures

CN¥31.13 Million
CNY

Innovita Biological Technology Co. Ltd. A Free Cash Flow Generation Index (2020–2025)

Historical FCF Generation Index trend for Innovita Biological Technology Co. Ltd. A across 6 annual periods. Explore capital reinvestment ratio of Innovita Biological Technology Co. Ltd. to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Innovita Biological Technology Co. Ltd. A (2020–2025)

Year-by-year Free Cash Flow Generation Index for Innovita Biological Technology Co. Ltd. A. For the full company profile including market capitalisation, see Innovita Biological Technology Co. Ltd. market capitalisation.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.84x CN¥162.00 Million CN¥193.13 Million CN¥31.13 Million ▼ -4.9%
2024 0.88x CN¥269.31 Million CN¥305.46 Million CN¥36.16 Million ▼ -5.7%
2023 0.93x CN¥242.89 Million CN¥259.85 Million CN¥16.97 Million ▲ +72.0%
2022 0.54x CN¥68.71 Million CN¥126.43 Million CN¥57.71 Million ▲ +35.8%
2021 0.40x CN¥42.52 Million CN¥106.27 Million CN¥63.75 Million ▼ -54.5%
2020 0.88x CN¥563.10 Million CN¥639.82 Million CN¥76.71 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).